Invasive Aspergillosis Completed Phase 1 Trials for Voriconazole (DB00582)

IndicationStatusPhase
DBCOND0031838 (Invasive Aspergillosis)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01080651Influence of Drug-drug Interactions on the Pharmacokinetics (PK) of Voriconazole